The Israeli government has approved some of the only clinical trials involving cannabis in the world, including an exciting look at the response of PTSD patients to cannabis high in THC. However, these trials have only just touched the tip of the iceberg. And while some pharmaceutical companies have taken cautious interest in prefabricating the elements of marijuana and running their own trials, they still seem generally unsure of how to brand and patent such a complex product of Mother Nature.
